Combidex faces panel review
This article was originally published in The Gray Sheet
Executive Summary
Advanced Magnetics' iron oxide nanoparticle-based MRI contrast agent will be evaluated by CDER's Oncologic Drug Advisory Committee March 3. The panel presentation will be jointly prepared by Advanced Magnetics and Cytogen, which holds exclusive U.S. licensing and marketing rights to the product. Combidex's user fee goal date is March 30...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.